ATE232736T1 - Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten - Google Patents

Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten

Info

Publication number
ATE232736T1
ATE232736T1 AT96308853T AT96308853T ATE232736T1 AT E232736 T1 ATE232736 T1 AT E232736T1 AT 96308853 T AT96308853 T AT 96308853T AT 96308853 T AT96308853 T AT 96308853T AT E232736 T1 ATE232736 T1 AT E232736T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
bismut
compositions
urogenital disorders
Prior art date
Application number
AT96308853T
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE232736T1 publication Critical patent/ATE232736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96308853T 1995-12-07 1996-12-05 Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten ATE232736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56885295A 1995-12-07 1995-12-07

Publications (1)

Publication Number Publication Date
ATE232736T1 true ATE232736T1 (de) 2003-03-15

Family

ID=24273004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96308853T ATE232736T1 (de) 1995-12-07 1996-12-05 Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten

Country Status (8)

Country Link
US (1) US5882686A (de)
EP (1) EP0776665B1 (de)
AT (1) ATE232736T1 (de)
DE (1) DE69626260T2 (de)
DK (1) DK0776665T3 (de)
ES (1) ES2192219T3 (de)
NO (1) NO314979B1 (de)
PT (1) PT776665E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767699A1 (fr) 1997-08-28 1999-02-26 Oreal Composition filmogene epaissie

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (de) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
CA2087596A1 (en) * 1990-07-20 1992-01-21 John Rhodes Products and processes for the treatment of the alimentary canal
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
DE69626260T2 (de) 2003-12-04
PT776665E (pt) 2003-06-30
DE69626260D1 (de) 2003-03-27
US5882686A (en) 1999-03-16
EP0776665B1 (de) 2003-02-19
NO965191D0 (no) 1996-12-05
DK0776665T3 (da) 2003-03-31
NO314979B1 (no) 2003-06-23
ES2192219T3 (es) 2003-10-01
NO965191L (no) 1997-06-09
EP0776665A1 (de) 1997-06-04

Similar Documents

Publication Publication Date Title
ATE180777T1 (de) 2-aminomethyl-chromane als wirkstoffe in arzneimitteln zur behandlung von erkrankungen des zentralnervensystems
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
ATE229806T1 (de) Wirkstoff zur behandlung neurodegenerativer störungen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
DE69622005D1 (de) Zusammensetzung zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut und eine oder mehrere antimikrobielle Mitteln enthalten
DE3587978D1 (de) Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs.
ATE232736T1 (de) Zusammensetzungen zur vorbeugung und behandlung von urogenitalen störungen, die wismut enthalten
DE69626916D1 (de) Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten
ATE231726T1 (de) Wismuth und eine oder mehrere antimikrobielle mittel enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
ES2173334T3 (es) Composiciones que contienen bismuto, para la prevencion y tratamiento de trastornos gastrointestinales.
ATE212229T1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0776665

Country of ref document: EP

REN Ceased due to non-payment of the annual fee